​

InflaRx (IFRX) Stock Forecast, Price Target & Predictions

OverviewOwnershipChart

IFRX Stock Forecast

InflaRx (IFRX) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $2.00, with a high of $2.00 and a low of $2.00. This represents a 32.45% increase from the last price of $1.51.

High: $2 Avg: $2 Low: $2 Last Closed Price: $1.51

IFRX Stock Rating

InflaRx stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 1 Strong Buy (7.14%), 11 Buy (78.57%), 1 Hold (7.14%), 1 Sell (7.14%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 1 1 11 1 Strong Sell Sell Hold Buy Strong Buy

IFRX Price Target Upside V Benchmarks

TypeNameUpside
StockInflaRx32.45%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$2.00
Last Closing Price$1.51$1.51$1.51
Upside/Downside--32.45%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25251--8
Sep, 25151--7
Aug, 25151--7
Jul, 25151--7
Jun, 25151--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 29, 2025Raymond James$2.00$0.85135.29%32.45%
Jan 06, 2023H.C. Wainwright$6.00$2.92105.48%297.35%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 29, 2025Raymond JamesStrong BuyOutperformdowngrade
Mar 26, 2025GuggenheimBuyBuyhold
Apr 06, 2023Raymond JamesStrong BuyStrong Buyhold
Apr 05, 2023GuggenheimBuyupgrade

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.26$-1.10$-0.76-----
Avg Forecast$-1.11$-1.05$-0.69$-0.93$-0.97$-0.78$-0.20$0.26
High Forecast$-0.11$-0.11$-0.64$-0.91$-0.84$-0.09$-0.02$0.53
Low Forecast$-2.60$-2.46$-0.73$-0.94$-1.09$-1.57$-0.41$0.03
Surprise %13.51%4.76%10.14%-----

Revenue Forecast

$0 $50M $100M $150M $200M $250M Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported--$61.80K-----
Avg Forecast$31.96K$4.31M$4.49M$217.94K$771.30K$17.97M$82.09M$139.92M
High Forecast$65.10K$8.78M$11.15M$335.99K$1.42M$32.07M$146.52M$249.75M
Low Forecast$9.91K$1.34M$1.12M$90.81K$192.82K$5.68M$25.97M$44.26M
Surprise %---98.62%-----

Net Income Forecast

$-150M $-110M $-70M $-30M $10M $50M Dec 20 Dec 21 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-34.01M$-45.65M$-41.79M-----
Avg Forecast$-60.95M$-57.63M$-37.88M$-50.85M$-53.22M$-42.61M$-11.23M$14.46M
High Forecast$-6.30M$-5.95M$-35.32M$-49.87M$-46.33M$-4.74M$-1.25M$29.21M
Low Forecast$-143.11M$-135.33M$-39.93M$-51.83M$-60.10M$-86.10M$-22.70M$1.61M
Surprise %-44.20%-20.78%10.32%-----

IFRX Forecast FAQ

Is InflaRx stock a buy?

InflaRx stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 11 Buy, 1 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that InflaRx is a favorable investment for most analysts.

What is InflaRx's price target?

InflaRx's price target, set by 14 Wall Street analysts, averages $2 over the next 12 months. The price target range spans from $2 at the low end to $2 at the high end, suggesting a potential 32.45% change from the previous closing price of $1.51.

How does InflaRx stock forecast compare to its benchmarks?

InflaRx's stock forecast shows a 32.45% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for InflaRx over the past three months?

  • October 2025: 25.00% Strong Buy, 62.50% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.

What is InflaRx’s EPS forecast?

InflaRx's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.93, marking a 22.37% increase from the reported $-0.76 in 2023. Estimates for the following years are $-0.97 in 2025, $-0.78 in 2026, $-0.2 in 2027, and $0.26 in 2028.

What is InflaRx’s revenue forecast?

InflaRx's average annual revenue forecast for its fiscal year ending in December 2024 is $217.94K, reflecting a 252.68% increase from the reported $61.8K in 2023. The forecast for 2025 is $771.3K, followed by $17.97M for 2026, $82.09M for 2027, and $139.92M for 2028.

What is InflaRx’s net income forecast?

InflaRx's net income forecast for the fiscal year ending in December 2024 stands at $-50.852M, representing an 21.68% increase from the reported $-41.793M in 2023. Projections indicate $-53.216M in 2025, $-42.612M in 2026, $-11.235M in 2027, and $14.46M in 2028.